This study observed reduced breast cancer risk among women with comparatively high OPG concentrations, but given a small number of incident cases (n = 76), risk by tumor subtypes (e.g., by estrogen (ER) and progesterone (PR) receptor status) was not investigated. The gene discussed is ESR1; the disease is breast cancer.